Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q2 2024 Earnings Call Transcript
Operator: Good day and welcome to the PacBio Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Pacific Biosciences Of California Inc. (PACB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 33,212,454 | $45,501,063 | -1% | 0.4% |
| 2. | Millennium Management Israel Englander | 4,629,627 | $6,342,589 | +92% | 0% |
| 3. | Soros Fund Management George Soros | 1,698,000 | $2,326,260 | +4% | 0.04% |
| 4. | D E Shaw D. E. Shaw | 1,645,499 | $2,254,334 | +104% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,611,300 | $2,207,481 | +227% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.40 | 40,000 | Director | 40,000 | 2024-03-06 | Filing | |
| $2.01 | 1 | Officer | 215,156 | 2018-09-01 | Filing | |
| $2.01 | 5,989 | Officer | 215,155 | 2018-03-01 | Filing | |
| $4.07 | 3,244 | Officer | 194,166 | 2017-09-01 | Filing | |
| $4.07 | 3,212 | Officer | 190,922 | 2017-03-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.59 | 26,760 | Officer | 869,730 | 2024-08-19 | Filing | |
| $1.66 | 38,011 | Officer | 1,630,815 | 2024-08-16 | Filing | |
| $2.03 | 5,275 | Officer | 211,941 | 2024-05-20 | Filing | |
| $4.87 | 2,968 | Officer | 217,216 | 2024-03-04 | Filing | |
| $4.87 | 9,186 | Officer | 1,668,826 | 2024-03-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,789,552 | $262,805,506 | 0% | |
| 2. | 24,642,666 | $241,744,552 | 0% | |
| 3. | 17,591,915 | $172,576,686 | 21.5% | |
| 4. | 13,200,375 | $129,627,683 | 1.24% | |
| 5. | 13,200,375 | $129,495,679 | 0.09% |
News See All
10 Micro Cap Stocks That Will Skyrocket
One of the more well known quotes of Warren Buffett is "Only buy something that you'd be perfectly happy to hold if the market shut down for 10 years." The learning from this quote is simple.
Top 10 Small-Cap Stocks with Highest Upside Potential
Most giant companies start as small-cap, but by continuously developing and growing their earnings, their share price increases making them large or mega-cap companies, and along the way smart investors...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call Transcript
Operator: Hello and welcome to the PacBio First Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
12 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 12 best medical stocks to buy under $10.
14 Best Beaten Down Stocks To Buy Right Now
In this piece, we will take a look at the 14 best beaten down stocks to buy right now.
5 Best Falling Stocks To Buy Right Now
In this piece, we will take a look at the five best falling stocks to buy now.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2023 Earnings Call Transcript
Pacific Biosciences of California, Inc. reports earnings inline with expectations. Reported EPS is $-0.31 EPS, expectations were $-0.31. Pacific Biosciences of California, Inc.
Top 11 CRISPR Stocks To Invest In
Genome editing refers to a set of technologies enabling scientists to modify an organism's DNA by adding, removing, or altering genetic material at specific locations in the genome, as defined by MedlinePlus...
Billionaire Hedge Funds
